Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
P.1.14 (Gamma)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.600NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.600NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.1.12 (Gamma)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.1.12 (Gamma)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.525 (Eta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.525 (Eta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.6 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.6 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.5.5 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.5.5 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.1.7 (Gamma)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.1.7 (Gamma)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.45NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.45NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BN.1.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1.7NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.5.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.5.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.41NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.41NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.75.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.75.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.1.20NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1.20NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.7.16NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.7.16NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.3.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.3.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CQ.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CQ.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-21584South Korea
EC.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EC.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.52NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.52NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XMNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XMNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.21NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.21NWon-NGTTGCGACTACGTGATGAGG20552884928830R-21584South Korea
BA.2.31NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.31NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CP.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CP.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBGNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBGNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.98 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.98 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.32NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.32NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.1.13NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used